AbCellera Biologics Inc. Common Shares vs. Johnson & Johnson
AbCellera Biologics Inc. Common Shares and Johnson & Johnson are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABCL | JNJ | |
|---|---|---|
| Market Cap | $3.98 billion | $664.95 billion |
JNJ leads on 1 of 1 size & scale factors.
Dividend
| ABCL | JNJ | |
|---|---|---|
| Dividend Yield | — | 1.94% |
ABCL and JNJ split the dividend factors evenly.
Risk & Sentiment
| ABCL | JNJ | |
|---|---|---|
| Short Interest | 0.31% | 0.67% |
ABCL leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABCL overview, ABCL financials, JNJ overview, JNJ financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.